Trial Profile
Phase 1-2 study of the association of Gemzar-cisplatin-concurrent radiotherapy in patients with non-metastatic tumors of the bladder
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Aug 2015
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Bladder cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Mar 2010 Phase I results (n=14) presented at ASCO Genitourinary Cancers Symposium 2010.
- 18 Dec 2009 Planned end date (1 Apr 2010) added as reported by ClinicalTrials.gov.
- 20 Nov 2007 New trial record.